DUBLIN--(BUSINESS WIRE)--The "US Sexually-Transmitted Diseases (STD) Diagnostic Testing Market, 2021" report has been added to ResearchAndMarkets.com's offering.
This report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhoea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals, Commercial, Physician Offices, and Public Health Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analysers used for STD testing;
- Profiles key suppliers and potential market entrants developing innovative technologies and products; and
- Analyses emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Key Topics Covered
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
B. Instrumentation Review of Leading Analysers Marketed
C. Emerging Diagnostic Technologies
Companies Featured
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako
For more information about this report visit https://www.researchandmarkets.com/research/bg7blf/us?w=4
